Mr Marco Gerlinger, Consultant Medical Oncologist
Mr Marco Gerlinger
Consultant Medical Oncologist
Mr Marco Gerlinger FRCP MD
Consultant Medical Oncologist
Mr Marco Gerlinger
Consultant Medical Oncologist FRCP MD
Mr Gerlinger is a Consultant Medical Oncologist
Areas of expertise
- Anal cancer
- Bowel cancer
- Colon cancer
- Colorectal cancer
- Gastrointestinal cancers
Make an appointment
Address
-
The Harley Street Clinic
35 Weymouth Street, London, W1G 8BJ
-
LOC - Leaders in Oncology Care
95 Harley Street, London, W1G 6AF
-
LOC at Chelsea
102 Sydney Street, Chelsea, London, SW3 6NJ
About Mr Marco Gerlinger
GMC number: 6117372
Year qualified: 2003
Place of primary qualification: Ludwig Maximilian University of Munich
Areas of expertise
- Adenocarcinoma
- Anal cancer
- Biological therapy
- Bowel cancer
- Cancer care
- Cancer genomics
- Chemotherapy
- Clinical trials
- Colon cancer
- Colorectal cancer
- Gastrointestinal cancers
- Genetic testing
- Immunotherapy
- Liver metastases
- Lynch syndrome
- Medical oncology
- Metastases
- Neoadjuvant
- Oesophageal cancer
- Oligometastic disease
- Rectal cancer
- Small bowel cancer
- Stomach (gastric) cancer
- Targeted therapy
Professional memberships
Articles by Mr Marco Gerlinger
Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer.
Elevated LDH predicts poor outcome of recurrent germ cell tumours treated with dose dense chemotherapy.
Ultra-deep T cell receptor sequencing reveals the complexity and intratumour heterogeneity of T cell clones in renal cell carcinomas.
Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale.
Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine.
Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma.
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.
Cancer (r)evolution.
Treatment and Survival Outcome of BRAF-Mutated Metastatic Colorectal Cancer: A Retrospective Matched Case-Control Study.
Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice.
